Harnessing ATTOBODY® technology to bring treatments to patients where none exist or where current solutions fall short.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.05.2024 | Series B | $105M | - |
Mentions in press and media 2
| Date | Title | Description |
| 10.05.2024 | Attovia Therapeutics Raises $105M in Series B Financing | Attovia Therapeutics, a Fremont, CA-based developer of a pipeline of biotherapeutics with an initial focus on immune-mediated diseases, raised $105m in Series B financing.
The round, which brought the total amount to $165m, was led by Goldm... |
| - | Attovia Therapeutics | “Harnessing ATTOBODY® technology to bring treatments to patients where none exist or where current solutions fall short.” |
Reviews 0
